Back

Smoking Status and Cardiovascular Mortality Differ by Arterial Stiffness Level Assessed by Pulse Pressure Index

Cheon, P.; Mostafa, M. A.; Grdzelishvili, A.; Cornea, D.; Liu, J.; Kazibwe, R.

2026-02-11 epidemiology
10.64898/2026.02.09.26345932 medRxiv
Show abstract

ObjectiveTo examine whether the association between smoking status and cardiovascular (CV) mortality differs by arterial stiffness, assessed by pulse pressure index (PPI), among U.S. adults without baseline cardiovascular disease (CVD). MethodsUsing data from the National Health and Nutrition Examination Survey (NHANES) 2005-2016, we analyzed 16,605 adults aged 40-79 years without baseline CVD, with mortality follow-up through December 31, 2019. PPI was calculated as (systolic blood pressure [SBP] - diastolic blood pressure [DBP])/SBP and split at the cohort median (0.415) as low versus high. Smoking status was classified as never, former, or current, yielding six joint PPI-smoking groups. Cox models estimated hazard ratios (HRs) and 95% confidence intervals (CIs) for CV mortality, adjusting for demographics and cardiometabolic risk factors. ResultsOver a median follow-up of 8.4 years, 518 CV deaths (3.1%) occurred. Among individuals with low PPI, former smokers had CV mortality comparable to never smokers (HR 0.86, 95% CI 0.56-1.33), whereas current smokers remained at elevated risk (HR 2.51, 95% CI 1.65-3.81). This pattern was not observed in the high PPI stratum, where both former and current smokers had significantly higher CV mortality than never smokers. ConclusionFormer smokers with low PPI had CV mortality similar to never smokers, whereas former smokers with high PPI remained at elevated risk. These findings suggest that the CV benefit of smoking cessation may be greatest when arterial stiffness is minimal, supporting early cessation before substantial vascular aging occurs.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Journal of the American Heart Association
119 papers in training set
Top 0.2%
18.5%
2
The Journals of Gerontology: Series A
25 papers in training set
Top 0.2%
6.4%
3
Clinical Epigenetics
53 papers in training set
Top 0.2%
4.9%
4
Scientific Reports
3102 papers in training set
Top 27%
4.4%
5
Atherosclerosis
29 papers in training set
Top 0.4%
4.0%
6
PLOS ONE
4510 papers in training set
Top 35%
4.0%
7
European Journal of Preventive Cardiology
13 papers in training set
Top 0.1%
4.0%
8
Annals of Epidemiology
19 papers in training set
Top 0.1%
3.1%
9
GeroScience
97 papers in training set
Top 0.7%
2.8%
50% of probability mass above
10
European Journal of Epidemiology
40 papers in training set
Top 0.3%
1.9%
11
Arteriosclerosis, Thrombosis, and Vascular Biology
65 papers in training set
Top 1.0%
1.9%
12
BMC Infectious Diseases
118 papers in training set
Top 2%
1.8%
13
Circulation
66 papers in training set
Top 2%
1.7%
14
Nature Communications
4913 papers in training set
Top 55%
1.3%
15
Frontiers in Cardiovascular Medicine
49 papers in training set
Top 2%
1.2%
16
The Journal of Infectious Diseases
182 papers in training set
Top 3%
1.2%
17
Hypertension
32 papers in training set
Top 0.5%
1.2%
18
PLOS Medicine
98 papers in training set
Top 3%
1.2%
19
Journal of Internal Medicine
12 papers in training set
Top 0.5%
0.9%
20
Aging Cell
144 papers in training set
Top 3%
0.9%
21
BMJ Open
554 papers in training set
Top 11%
0.9%
22
BMC Cardiovascular Disorders
14 papers in training set
Top 1%
0.8%
23
International Journal of Epidemiology
74 papers in training set
Top 2%
0.8%
24
BMC Nephrology
13 papers in training set
Top 0.3%
0.8%
25
Epigenetics
43 papers in training set
Top 0.9%
0.8%
26
Aging
69 papers in training set
Top 3%
0.8%
27
The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
22 papers in training set
Top 0.4%
0.8%
28
American Journal of Physiology-Heart and Circulatory Physiology
32 papers in training set
Top 1%
0.8%
29
BMC Medicine
163 papers in training set
Top 7%
0.8%
30
BMJ Open Diabetes Research & Care
15 papers in training set
Top 1%
0.8%